All clinical trials conducted at the hospital are listed and described on the GPR Hospital website under the “Clinical Trials” section. This allows patients to get an overview of the clinical trials offered at the GPR Hospital.
If interested, they can contact their treating physician or the “Research and Innovation” department directly. However, patients may also be approached by their physician about participating in a clinical trial.
Internal Medicine (Urinary Tract, Intestines, Lungs, Stomach, Other)
Overview of Studies
| Clinical Picture | Study Name | Study Description | Information | |
| Hyperparathyroidism—Parathyroid Disorder | StuDoQ | StuDoQ Registry Quality Assurance Study | Information Sheet | |
| LARS Syndrome | CP DKZLARS | A multicenter, open-label, prospective, randomized, comparative study with two parallel follow-up regimens in patients with low anterior resection syndrome (LARS) following surgical treatment for rectal cancer | Information Sheet | |
| Non-small-cell lung cancer | UmbREALung | A retrospective and prospective observational study involving multiple cohorts of patients with non-small cell lung cancer (NSCLC) receiving drugs approved for routine clinical use that were developed by AstraZeneca (AZ) or as part of an AZ alliance | Information Sheet | |
Renal Cell Carcinoma/Urothelial/ Bladder Carcinoma | CARAT | Clinical platform for research into molecular alterations and the treatment of renal cell carcinoma (mRCC) | Fact Sheet | |
| Prostate Cancer | PROceed | A prospective, non-interventional study to investigate the clinical data and characteristics of patients with metastatic castration-resistant prostate cancer | Fact Sheet | |
| Colon Cancer | COMPASS | A randomized, controlled, parallel-group, open-label, multicenter study to investigate mortality and quality of life following emergencies in obstructive colorectal cancer | Information Sheet | |
| Orthopedics - Hip Surgery - Thrombosis Prevention | ENABLE-HIP | Multicenter randomized study on shortened anticoagulation therapy and increased mobilization following hip surgery | Information Sheet | |
| Esophageal and Gastric Cancer | SAPHIR | Non-interventional study for patients with esophageal and gastric cancer | Information Sheet | |
| Surgery - Hernias | Herniamed | Herniamed Quality Assurance Study | Information Sheet |
Cardiology (Heart)
Overview of Studies
| Clinical Picture | Study Name | Study Description | Information |
| Heart Rhythm Disorder/Atrial Fibrillation | CLEARANCE | Left Atrial Appendage Occlusion in Patients with Atrial Fibrillation and a History of Cerebral Hemorrhage Compared to Standard Medical Therapy: A Prospective Randomized Clinical Trial | Information Sheet |
| Atherosclerotic cardiovascular disease and elevated lipoprotein(a) | ACCLAIM-Lp(a) | This is a current Phase III study investigating the effect of the drug lepodisiran on the reduction of serious adverse cardiovascular events in adults with elevated lipoprotein(a) | Information Sheet |
Breast Cancer Center and Gynecologic Cancer Center
Overview of Studies
| Clinical Picture | Study Name | Study Description | Information |
| Breast Cancer | CAROLEEN | A non-interventional study of Kisqali (ribociclib) in combination with an aromatase inhibitor for the adjuvant treatment of patients with HR+/HER2- early-stage breast cancer at high risk of recurrence to evaluate efficacy, the safety profile, adherence, and quality of life | Information Sheet |
| Breast Cancer | OPAL | Study for women with breast cancer. Treatment data and questionnaire responses will be collected from the participants. This is an observational study and will not influence the treatment method prescribed by the physician. | Information Sheet |
| Breast Cancer | PERFORM | An epidemiological, prospective observational study investigating the actual care received by patients with HR+/HER2- advanced breast cancer who are treated in the first-line setting with an endocrine-based palbociclib combination therapy in accordance with current treatment standards | Information Sheet |
| Breast Cancer | LOBSTER | A Phase II neoadjuvant study to evaluate capivasertib plus fulvestrant compared to fulvestrant alone in patients with primary lobular breast cancer and a high risk of recurrence | Fact Sheet |
| Breast Cancer | CAPTOR-BC | Study for Women with Breast Cancer to Document the Combination of Rivociclib and Endocrine Therapy | Information Sheet |
| Breast Cancer | CAMBRIA 1 | An open-label, randomized Phase III study to evaluate the efficacy and safety of extended therapy with camizestrant | Information Sheet |
| Breast Cancer | FLAMINGO 1 | A clinical, randomized, multicenter Phase III adjuvant immunotherapy trial with GLSI-100 to prevent the recurrence of breast cancer in HER2+ and HLA-A*02 patients | Information Sheet |
| Ovarian/Endometrial Cancer | SMARAGD | National, prospective, open-label, longitudinal, non-interventional, multicenter observational study (tumor registry). | Information Sheet |
Study Physicians









Clinical studies and medical documentation

Head of Research and Innovation, Head of IT
PD Dr. Eberhard Schneider
Tel.
06142 88-1901
e.schneider@gp-ruesselsheim.de

